DOJ Moves Certain Marijuana Products to Schedule III, Sets June Rescheduling Hearing
DOJ Moves Certain Marijuana Products to Schedule III, Sets June Rescheduling Hearing
The U.S. Department of Justice issued an Order on April 22, 2026 immediately placing all FDA-approved marijuana products and marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled Substances Act (CSA).... By: Jackson Lewis P.C.